Neurontin study more marketing than science: report | Reuters

Links shared publicly online about this topic.

  • 187
    total visits

Neurontin study more marketing than science: report | Reuters

reuters.com

NEW YORK (Reuters Health) - A study of the safety and effectiveness of an anti-epilepsy drug mislead doctors and patients about the point of the research, suggests a new report.Investigators writing

View full resource at reuters.com

Tags: Migraine Prevention Medication, Seizure Medication, Pharma, Healthy Living, Neurontin, Epilepsy Medication, Science, Medical

  • Share

Most Recently Shared on June 28, 2011 at 3:15 am By:

hrana Hisham Rana, MD

Report: Neurontin study more marketing than science (Archives of Internal Medicine) http://reut.rs/lFOPiY - #health #pharma

10 months ago...

Neurontin study more marketing than science: report | Reuters

reuters.com — “NEW YORK (Reuters Health) - A study of the safety and effectiveness of an anti-epilepsy drug mislead doctors and patients about the point of the research, suggests a new report.Investigators writingView full resource at reuters.com

  • View Related
  • Share

Most Recently Shared on June 27, 2011 at 11:46 pm By:

ivanoransky Ivan Oransky Doctor and Health Communicator

Neurontin study more marketing than science: report http://reut.rs/mlV8ed

10 months ago...

Neurontin study more marketing than science: report | Reuters

reuters.com — “NEW YORK (Reuters Health) - A study of the safety and effectiveness of an anti-epilepsy drug mislead doctors and patients about the point of the research, suggests a new report.Investigators writingView full resource at reuters.com

  • View Related
  • Share

Most Recently Shared on June 27, 2011 at 10:34 pm By:

Reuters_Health Reuters Health Health News

Neurontin study more marketing than science: report http://reut.rs/lpvCwE

10 months ago...

Advertisement